Home
Aspen Neuroscience

Aspen Neuroscience Market Share Analysis for November 2025

Aspen Neuroscience leverages stem cell biology and genomics for Parkinson’s disease.

Health > Biotechnology and Pharmaceuticals

Domainaspenneuroscience.com

Year Founded2018

Employees51 - 200

Annual Revenue$5M - $10M

Aspen Neuroscience

Aspen Neuroscience (including company regionals)

aspenneuroscience.com

See more website traffic and engagement information

Aspen Neuroscience Revenue up to November 2025 is 5M - 10M

revenue generated by Aspen Neuroscience top domains

Aspen Neuroscience top domains revenue over 3 years

Revenue for Aspen Neuroscience top domains

aspenneuroscience.com5M - 10M

See more with Sales Intelligence

Total visits to Aspen Neuroscience's top domains

Understand Aspen Neuroscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aspenneuroscience.com6.2K

See more with Sales Intelligence

Avg. visit duration in Aspen Neuroscience's top domains

Analyze Aspen Neuroscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aspenneuroscience.com00:00:56

See more with Sales Intelligence

Avg. pageviews on Aspen Neuroscience's top domains

See how Aspen Neuroscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aspenneuroscience.com2.71

See more with Sales Intelligence

Aspen Neuroscience top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ambrx.comCompany NameAmbrxEmployees51 - 200HQUnited States, California, La JollaAnnual revenue$10M - $15MTotal visits3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Aspen Neuroscience

These are the website technologies, by industry, used by Aspen Neuroscience top domains

Advertising (3)

Google Adsense

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Aspen Neuroscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAspen Neuroscience Inc. received financing of $115M in Series C on Nov 20th '25.SAN DIEGO, Nov. 20, 2025 /PRNewswire/ - Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the closing of a $115 million Series C financing round.

NewsAspen Neuroscience Inc. hires Cindy Perettie as Executive Vice President and Global Head of Kite.In conjunction with the financing, Cindy Perettie, Executive Vice President and Global Head of Kite, a Gilead Company, will join Aspen's board of directors.

NewsAspen Neuroscience Inc. launches Cohort 3 in Parkinson.Aspen Neuroscience launches Cohort 3 in Parkinson's trial with commercial-ready ANPD001.